Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis (2021)

First Author: Reis T
Attributed to:  VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.exppara.2020.108059

PubMed Identifier: 33338468

Publication URI: http://europepmc.org/abstract/MED/33338468

Type: Journal Article/Review

Parent Publication: Experimental Parasitology

ISSN: 0014-4894